New Method for Assessing Drug Resistance in Tumor Cells
Author Information
Author(s): L Homolyal, Z Hollo, M Mffllerl, EB Mechetner, B Sarkadil
Primary Institution: National Institute of Haematology, Blood Transfusion and Immunology, Budapest, Hungary
Hypothesis
A rapid and quantitative diagnostic method for estimating P-glycoprotein-related multidrug resistance in tumor cells is needed for effective chemotherapy.
Conclusion
The new calcein accumulation assay provides a reliable and sensitive measure of multidrug resistance in tumor cells.
Supporting Evidence
- The new assay allows for differentiation between drug-sensitive and drug-resistant cells in a short time frame.
- Calcein AM is a high-affinity substrate for the MDR1 transporter, enhancing the sensitivity of the assay.
- The method correlates well with the levels of P-glycoprotein expression and drug resistance in various cell lines.
Takeaway
Scientists created a new test to see how well cancer cells can resist drugs, which can help doctors choose better treatments.
Methodology
The study used a calcein accumulation method combined with immunorecognition and drug-resistance studies to assess P-glycoprotein expression and function in various tumor cell lines.
Limitations
The study may not account for non-functional P-glycoprotein or the presence of other drug resistance mechanisms.
Want to read the original?
Access the complete publication on the publisher's website